Neuberger Berman Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$159M Buy
331,269
+328,126
+10,440% +$87.1M 0.11% 218
2026
Q1
$345K Sell
3,143
-519,567
-99% -$74M ﹤0.01% 1780
2025
Q4
$87M Buy
522,710
+238,454
+84% +$39.9M 0.06% 345
2025
Q3
$55.7M Buy
284,256
+181,770
+177% +$29.9M 0.04% 450
2025
Q2
$9.27M Sell
102,486
-60,518
-37% -$4.78M 0.01% 815
2025
Q1
$9.73M Buy
+163,004
New +$15.1M 0.01% 792
2024
Q4
Sell
-99,112
Closed -$5.19M 2015
2024
Q3
$5.19M Sell
99,112
-374,683
-79% -$17.6M ﹤0.01% 934
2024
Q2
$28.7M Buy
473,795
+44,251
+10% +$3.07M 0.02% 560
2024
Q1
$31.9M Buy
+429,544
New +$31.8M 0.03% 544

Other funds holding ALAB

Neuberger Berman Group's ALAB Position: Q2 2026 in Review

Neuberger Berman Group increased its Astera Labs (ALAB) stake by 10,440% in Q2 2026, buying an estimated $87.1M and bringing the position to 331,269 shares worth $159M. The position accounts for 0.11% of the portfolio, ranked #218.

Neuberger Berman Group first reported a position in ALAB in Q1 2024 and has held it in 9 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Neuberger Berman Group held 331,269 shares of Astera Labs worth $159M as of Q2 2026.
  • Neuberger Berman Group bought 328,126 Astera Labs shares in Q2 2026, an estimated $87.1M.
  • Astera Labs made up 0.11% of Neuberger Berman Group's portfolio in Q2 2026, its #218 holding.
  • Neuberger Berman Group first reported a position in Astera Labs in Q1 2024 and has held it in 9 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.